参芪扶正注射液对非消化系统恶性肿瘤患者临床辅助治疗的研究进展

Research progress of Shenqi Fuzheng Injection in the clinical adjuvant treatment of patients with non-digestive system malignant tumor

恶性肿瘤治疗过程中产生的一系列不良反应给治疗效果带来严重影响。参芪扶正注射液因其减毒增效、改善患者免疫功能的作用,可以作为辅助治疗药物应用于肺癌,乳腺癌,宫颈癌等恶性肿瘤的临床治疗中,并取得了不错的效果。同时,对其作用机制的研究也得到越来越多的重视。

A series of adverse reactions in the treatment of malignant tumors have a serious impact on the therapeutic effect. Shenqi Fuzheng Injection can be used as adjuvant therapy in the clinical treatment of lung cancer, breast cancer, cervical cancer and other malignant tumors due to its effects of reducing toxicity, enhancing efficacy and improving patients′ immune function, and has achieved good results. At the same time, more and more attention has been paid to its mechanism of action.